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• Alzheimer’s Disease (AD) is the most common form of neurodegenerative dementia 
in Canada1.
• The pathogenesis of AD is characterized by the biochemical event of amyloid-β (Aβ) 
plaque accumulation in the brain2.
• Many researchers are investigating therapeutic options for the prevention and treat-
ments of AD using natural plant-based sources i.e. superfoods.
• Haskap berries (HBs) (Fig. 1) are originally native to Siberia and northeastern Asia 
but have recently expanded to the Canadian market3. 
• The compounds found in HBs, such as the anthocyanin cyanidin-3-glucoside (C3G), 
have demonstrated in purified in vitro studies to have beneficial effects on lifespan, 
development, and neuronal growth4.
• Due to the presence of C3G in HBs, there is the potential for the fruit to have 
neuroprotective effects against the accumulation of amyloid-β (Aβ) plaques.
• HBE is known to increase expression and nuclear translocation of  DAF-16 
transcription factor (TF) (Fig. 2C) which is involved in the stress response pathway7.
• In addition, DAF-16 upregulation is associated with delayed Aβ toxicity8.
• This research supports a causative link between the known upregulation of DAF-16 
by HBE and the effects of DAF-16 on delayed Aβ toxicity.
•  A transgenic C.elegans strain CL4176 was used as they produce β-amyloid protein 
under a temperature sensitive (23°C) repressible mRNA  surveillance system. 
• Accumulation of toxic levels of Aβ protein in the C.elegans results in total paralysis.
• CL4176 strain also has a characteristic rolling phenotype to differentiate the worms, 
(Fig. 3) from regular N2 worms that have S-shaped movement (Fig. 4).
• Age-synchronous worms were grown on experimental (HBE) and control (NGM)
conditions and then β-amyloid protein production was initiated at L3 life stage by 
temperature upshift from 16°C to 23°C.
• Onset of paralysis between the conditions was recorded every 2 hours from 24-40 
hours after temperature upshift. 
• Analysis of the paralysis phenotype was determined by the ability of the worm to 
move their posterior segment, complete a full body-wave movement, and respond 
to manual stimulus.
• Statistical analysis was conducted by OASIS 2, a surviorship analysis tool10.
• Transgenic C.elegans strain CL2006 was used, which constitutively produce 
β-amyloid protein, and toxic accumulation of β-amyloid protein in the C.elegans 
result in total paralysis.
• CL2006 strain also has the characteristic rolling phenotype (Fig. 4B).
• Age-synchronous worms were grown on experimental and control conditions and 
then stained with β-amyloid plaque sensitive X-34 dye.
• Qualitative β-amyloid plaque accumulations were recorded via fluorescence 
microscopy. Quantitative normalized fluorescence was compared between the groups 
via ImageJ, a image analysis software, and statistically analyzed by t-tests.
• Results of the neuroprotective assay demonstrate that HBE significantly delays the 
effects of β-amyloid protein toxicity in vivo.
• Results of the β-amyloid accumulation X-34 assay demonstrate that HBE signifi-
cantly reduced the amount of β-amyloid protein accumulation in vivo.
• Future studies using larger sample size studies of the β-amyloid accumulation X-34 
assay is necessary to ensure replicability of the study. 
• Integration of RT-PCR work would allow us to elucidate if DAF-16 is the gene 
responsible for the neuroprotective effects seen in the study.
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• In the first assay, triplicate studies were conducted as to determine the effect of HBE 
on delaying the paralysis brought on by the accumulation of β-amyloid protein in vivo.
• All three replicates resulted in consistent results and p-values <0.05 via statistical 
analysis by OASIS 2 (Fig. 5B)10.
• Interestingly, onset of paralysis in both control and experimental conditions was 
delayed by 4 hours across all replicates as compared to literature expectations.
• The delay in paralysis could be due to inconsistent upshift temperature, developmental 
stage, or differing lawn size shifting the kinetics of paralysis.
• The β-amyloid accumulation X-34 assay was conducted in triplicate to determine if the 
presence of HBE would significantly reduce the accumulation of the Aβ protein in vivo.
• Due to the lack of available procedures for the use of X-34 dye, a procedure for live 
staining was designed and carried out to effectively stain the β-amyloid in the live 
worms without sacrificing.
• The analysis via ImageJ excluded the body walls to isolate fluorescence by the 
protein accumulation.
• The three replicates resulted in consistent results and p-values <0.05 via statistical 
analysis by one tailed t-test assuming equal variance (Fig. 6F).
• Continue previous work into the investigation of the effects of  Haskap Berry Extract 
(HBE) on C. elegans.
• Determine if HBE has neuroprotective effects in C. elegans, in terms of delaying the 
onset of phenotypic symptoms, and reducing the accumulation of Aβ plaques.
• C. elegans were chosen for this experiment due to our vast knowledge of cellular 
pathways, the availability of inducible amyloid (Aβ) transgenic strains, and the ease 
of care within the laboratory9.
Fig. 1: (A) Close-up HBs morphology5. (B) HBs growing morphology6.
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Fig 2: (A) Three designations of DAF-16 localization. 
Represents cytoplasmic DAF-16 localization 
(B) Represents intermediate DAF-16 localization, 
(C) Represents nuclear DAF-16 localization. 
(D)DAF-16 pathway and the homologous pathway 
found in mammals. 
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 Fig. 5 (A). Survivorship curve that demonstrates the percentage of HBE and NGM worms affected by paralysis. The x-axis shows 
the number of hours since temperature upshift, and the y-axis shows the percent of each treatment not paralyzed at that time. Data 
was processed using OASIS 210. (B) Statistical analysis of the data of three replicates of the neuroprotection assay analyzed by 
OASIS 210. Significance is found at p<0.05.
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Fig. 6: (A). A qualitative look at HBE worms stained with X-34. (B). A qualitative look at NGM control worms stained with X-34. All 
photos were taken at the 565ms exposure. (C) A dead NGM control worm’s internal accumulation (arrows) of β-amyloid. (D)(E) An 
NGM control worm’s internal accumulation of β-amyloid. (F) The mean normalized fluorescence and p-values for the accumulation 
assay as analyzed by one tailed t-test. Data was replicated in triplicate studies and demonstrated consistency.
Fig. 3: Phenotypic movement 
patterns of strains. Scan QR.
Fig. 4: (A) N2 strain showing S-like movement (B) CL2006/CL4176 showing rolling 
movement (C) Paralyzed CL2006/CL4176.
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(replicate one)
100 0.0035
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(replicate two)
100 0.0042
NGM vs. HBE 
(replicate three) 
100 0.0004
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